Author:
Mak Lung-Yi,Yuen Man-Fung
Reference78 articles.
1. Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003;67(4):657–85.
2. Ahn SH, Marcellin P, Ma X, Caruntu FA, Tak WY, Elkhashab M, et al. Hepatitis B surface antigen loss with Tenofovir Disoproxil fumarate plus Peginterferon alfa-2a: week 120 analysis. Dig Dis Sci. 2018;63(12):3487–97.
3. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools [Internet]. 2020 [cited 20 Dec 2020]. Available from: http://www.allelefrequencies.net/hla6006a.asp?hla_selection=A*02:01.
4. Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, et al. Association between Seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2020.
5. Bazinet M, Pantea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, et al. Safety and efficacy of 48 weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated interferon alfa-2a in patients with chronic HBV infection naive to Nucleos(t)ide therapy. Gastroenterology. 2020;158(8):2180–94.